Insider · CIK 0001593087
Anthony Bergmann
Files at CAPR (CAPRICOR THERAPEUTICS, INC.). First filing Apr 1, 2026, latest Jun 29, 2026.
In brief
Anthony Bergmann files SEC Form 4 as CFO at CAPR (CAPRICOR THERAPEUTICS, INC.). Since Apr 1, 2026, Anthony Bergmann has reported 0 open-market buys worth $0 and 4 open-market sells worth $2.3M, the latest filed on Jun 29, 2026.
A track record needs three past buys with six months of prices behind them; Anthony Bergmann has 0, so none is measured yet.
The newest scored trade: sold $732k of CAPR on Jun 25, 2026, filed Jun 29, 2026, scored 36 (weak), under a 10b5-1 plan. In the last 12 months: 0 buys worth $0 and 4 sells worth $2.3M.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
CAPR: CAPRICOR THERAPEUTICS, INC.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 36Weak | CAPRICOR THERAPEUTICS, INC. | $732k 24,100 shares | -68% | +561% from low-14% from high | |
| 0Weak | CAPRICOR THERAPEUTICS, INC. | $27k 900 shares | -8% | +538% from low-17% from high | |
| 37Weak | CAPRICOR THERAPEUTICS, INC. | $793k 25,000 shares | -75% | +572% from low-13% from high | |
| 44Moderate | CAPRICOR THERAPEUTICS, INC. | $753k 25,000 shares | -75% | +561% from low-9% from high |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Mar 31, 2026 | CAPR CAPRICOR THERAPEUTICS, INC. | 75,000 0.13% of outstanding | $2.1M | Mar 31, 2026 | none |
Transactions
Every row this insider has filed, 25 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 25, 2026 | CAPR CAPRICOR THERAPEUTICS, INC. | MOption exercise Common Stock | +24,100 | $3.18 | $77k | 35,323 | Jun 29, 2026 |
| Jun 25, 2026 | CAPR CAPRICOR THERAPEUTICS, INC. | SOpen-market sale Common Stock10b5-1 | -24,100 | $30.38 | $732k | 11,223 | Jun 29, 2026 |
| Jun 25, 2026 | CAPR CAPRICOR THERAPEUTICS, INC. | MOption exercise Stock Option (Right to Buy)derivative | -24,100 | $0.00 | $0 | 91,980 | Jun 29, 2026 |
| Jun 22, 2026 | CAPR CAPRICOR THERAPEUTICS, INC. | MOption exercise Common Stock | +500 | $3.18 | $1,590 | 11,723 | Jun 24, 2026 |
| Jun 22, 2026 | CAPR CAPRICOR THERAPEUTICS, INC. | SOpen-market sale Common Stock10b5-1 | -500 | $30.00 | $15k | 11,223 | Jun 24, 2026 |
| Jun 24, 2026 | CAPR CAPRICOR THERAPEUTICS, INC. | MOption exercise Common Stock | +400 | $3.18 | $1,272 | 11,623 | Jun 24, 2026 |
| Jun 24, 2026 | CAPR CAPRICOR THERAPEUTICS, INC. | SOpen-market sale Common Stock10b5-1 | -400 | $30.00 | $12k | 11,223 | Jun 24, 2026 |
| Jun 22, 2026 | CAPR CAPRICOR THERAPEUTICS, INC. | MOption exercise Stock Option (Right to Buy)derivative | -500 | $0.00 | $0 | 116,480 | Jun 24, 2026 |
| Jun 24, 2026 | CAPR CAPRICOR THERAPEUTICS, INC. | MOption exercise Stock Option (Right to Buy)derivative | -400 | $0.00 | $0 | 116,080 | Jun 24, 2026 |
| May 18, 2026 | CAPR CAPRICOR THERAPEUTICS, INC. | MOption exercise Common Stock | +3,000 | $1.39 | $4,170 | 11,223 | May 19, 2026 |
| May 18, 2026 | CAPR CAPRICOR THERAPEUTICS, INC. | MOption exercise Stock Option (Right to Buy)derivative | -3,000 | $0.00 | $0 | 0 | May 19, 2026 |
| May 1, 2026 | CAPR CAPRICOR THERAPEUTICS, INC. | MOption exercise Common Stock10b5-1 | +25,000 | $3.18 | $80k | 33,223 | May 4, 2026 |
| May 1, 2026 | CAPR CAPRICOR THERAPEUTICS, INC. | SOpen-market sale Common Stock10b5-1 | -25,000 | $31.70 | $793k | 8,223 | May 4, 2026 |
| May 1, 2026 | CAPR CAPRICOR THERAPEUTICS, INC. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -25,000 | $0.00 | $0 | 116,980 | May 4, 2026 |
| Mar 31, 2026 | CAPR CAPRICOR THERAPEUTICS, INC. | MOption exercise Common Stock10b5-1 | +25,000 | $3.18 | $80k | 33,223 | Apr 1, 2026 |
| Mar 31, 2026 | CAPR CAPRICOR THERAPEUTICS, INC. | SOpen-market sale Common Stock10b5-1 | -25,000 | $30.13 | $753k | 8,223 | Apr 1, 2026 |
| Mar 31, 2026 | CAPR CAPRICOR THERAPEUTICS, INC. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -25,000 | $0.00 | $0 | 141,980 | Apr 1, 2026 |
| Jan 5, 2026 | CAPR CAPRICOR THERAPEUTICS, INC. | AGrant or award Stock Option (Right to Buy)derivative | +25,000 | $0.00 | $0 | 25,000 | Jan 7, 2026 |
| Jan 5, 2026 | CAPR CAPRICOR THERAPEUTICS, INC. | AGrant or award Stock Option (Right to Buy)derivative | +25,000 | $0.00 | $0 | 25,000 | Jan 7, 2026 |
| Jan 5, 2026 | CAPR CAPRICOR THERAPEUTICS, INC. | AGrant or award Restricted Stock Unitsderivative | +2,500 | $0.00 | $0 | 2,500 | Jan 7, 2026 |
| Mar 3, 2025 | CAPR CAPRICOR THERAPEUTICS, INC. | MOption exercise Common Stock | +2,500 | $1.39 | $3,475 | 8,223 | Mar 4, 2025 |
| Mar 3, 2025 | CAPR CAPRICOR THERAPEUTICS, INC. | MOption exercise Stock Option (Right to Buy)derivative | -2,500 | $0.00 | $0 | 0 | Mar 4, 2025 |
| Jan 2, 2025 | CAPR CAPRICOR THERAPEUTICS, INC. | AGrant or award Common Stock | +3,342 | $0.00 | $0 | 5,723 | Jan 6, 2025 |
| Jan 2, 2025 | CAPR CAPRICOR THERAPEUTICS, INC. | AGrant or award Stock Option (Right to Buy)derivative | +75,000 | $0.00 | $0 | 75,000 | Jan 6, 2025 |
| Jan 2, 2025 | CAPR CAPRICOR THERAPEUTICS, INC. | AGrant or award Stock Option (Right to Buy)derivative | +6,170 | $0.00 | $0 | 6,170 | Jan 6, 2025 |
Questions about Anthony Bergmann
Answered from the filings on this page, as of the latest one.
Is Anthony Bergmann buying or selling?
In the last 12 months Anthony Bergmann reported 0 open-market buys worth $0 and 4 open-market sells worth $2.3M on SEC Form 4; the latest was sold $732k of CAPR on Jun 25, 2026. Grants, option exercises and tax withholding are not counted.
How did Anthony Bergmann's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Anthony Bergmann has 0.
Where does Anthony Bergmann file Form 4?
Anthony Bergmann has filed Form 4 at CAPR (CAPRICOR THERAPEUTICS, INC.) as CHIEF FINANCIAL OFFICER. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.